$0.5166
At close: Jul 3, 10:58 AM EDT
Comments
Loading...
Defence Therapeutics Stock Guidance | OTC:DTCFF | Benzinga
Defence Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Defence Therapeutics Inc (DTCFF) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Defence Therapeutics (DTCFF)?
There have been no specific sales or earnings guidance reported for Defence Therapeutics in recent months.
Browse guidance and forecast on all stocks.
